4
Changes in Ownership
Alzamend Neuro, Inc. Filed Acc 0001864317-22-000007
Chief Financial Officer bought 10,000 shares at $1.11 ($11,092)
From the SEC's structured data for this filing
Trades in this filing
Katzoff David J · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-14 | Purchase : show line 1 in the form | +10,000 | $1.11 | $11,092 | 28,000 | D |
| Open-market purchases · 10,000 sh · avg $1.11 · $11,092 | ||||||
Loading xslF345X03/primary_doc.xml…